Sernova (TSE:SVA) Shares Down 6.1% - Here's Why

Sernova Corp. (TSE:SVA - Get Free Report) shares fell 6.1% during trading on Monday . The stock traded as low as C$0.16 and last traded at C$0.16. 302,755 shares changed hands during trading, an increase of 116% from the average session volume of 140,272 shares. The stock had previously closed at C$0.17.

Sernova Price Performance

The firm has a market cap of C$52.16 million, a P/E ratio of -1.50 and a beta of 1.35. The firm's fifty day simple moving average is C$0.19 and its 200 day simple moving average is C$0.19. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.